X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (980) 980
Publication (70) 70
Book Review (13) 13
Book / eBook (4) 4
Book Chapter (4) 4
Magazine Article (4) 4
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (941) 941
female (753) 753
male (559) 559
adult (469) 469
index medicus (450) 450
condylomata acuminata - prevention & control (433) 433
adolescent (381) 381
papillomavirus infections - prevention & control (323) 323
human papillomavirus (297) 297
condylomata acuminata - epidemiology (296) 296
uterine cervical neoplasms - prevention & control (246) 246
condylomata acuminata - virology (234) 234
young adult (233) 233
infectious diseases (219) 219
genital warts (212) 212
middle aged (212) 212
condylomata acuminata (204) 204
cervical cancer (200) 200
vaccination (196) 196
child (189) 189
papillomavirus infections - epidemiology (184) 184
papillomavirus infections (181) 181
prevalence (180) 180
risk factors (176) 176
vaccines (151) 151
women (150) 150
warts (148) 148
papillomavirus vaccines - administration & dosage (146) 146
cancer (142) 142
condylomata acuminata - therapy (134) 134
condyloma acuminatum (133) 133
immunology (130) 130
prevention (129) 129
papillomavirus vaccines (127) 127
incidence (125) 125
uterine cervical neoplasms - virology (125) 125
infection (123) 123
hpv (110) 110
papillomavirus infections - virology (110) 110
research (106) 106
condylomata acuminata - diagnosis (105) 105
cervical-cancer (104) 104
health aspects (103) 103
immunization (103) 103
papillomavirus vaccines - immunology (102) 102
aged (98) 98
men (98) 98
infections (97) 97
united-states (95) 95
anogenital warts (94) 94
epidemiology (94) 94
sexually transmitted diseases (93) 93
young-women (92) 92
condylomata acuminata - drug therapy (86) 86
sexual behavior (86) 86
papillomavirus infections - complications (85) 85
public, environmental & occupational health (83) 83
particle vaccine (82) 82
human papillomavirus recombinant vaccine quadrivalent, types 6, 11, 16, 18 (81) 81
uterine cervical neoplasms - epidemiology (81) 81
papillomavirus vaccines - therapeutic use (80) 80
medicine, general & internal (78) 78
papillomaviridae (76) 76
health knowledge, attitudes, practice (73) 73
treatment outcome (73) 73
cervical intraepithelial neoplasia (72) 72
dermatology (72) 72
efficacy (72) 72
natural-history (70) 70
care and treatment (69) 69
papillomaviridae - isolation & purification (67) 67
abridged index medicus (65) 65
cross-sectional studies (65) 65
diagnosis (65) 65
human-papillomavirus infection (65) 65
risk-factors (65) 65
condylomata acuminata - pathology (64) 64
papillomaviridae - immunology (62) 62
virus diseases (62) 62
lesions (61) 61
obstetrics & gynecology (61) 61
papillomaviruses (61) 61
analysis (60) 60
condylomata acuminata - immunology (59) 59
papillomavirus infections - transmission (58) 58
research article (58) 58
human-papillomavirus (56) 56
papillomavirus infections - immunology (56) 56
public health (56) 56
papillomavirus vaccines - economics (55) 55
surveys and questionnaires (55) 55
womens health (55) 55
condylomata acuminata - economics (52) 52
condylomata acuminata - complications (51) 51
cost-benefit analysis (51) 51
diseases (51) 51
hpv vaccine (50) 50
microbiology (49) 49
pregnancy (49) 49
retrospective studies (49) 49
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (881) 881
German (29) 29
French (24) 24
Spanish (10) 10
Chinese (8) 8
Italian (6) 6
Swedish (5) 5
Hungarian (4) 4
Russian (4) 4
Danish (3) 3
Japanese (3) 3
Bulgarian (2) 2
Czech (2) 2
Polish (2) 2
Croatian (1) 1
Dutch (1) 1
Korean (1) 1
Persian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 5, pp. 565 - 580
Journal Article
BMJ, ISSN 0959-8138, 2010, Volume 341, Issue 7766, pp. 239 - 239
Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal... 
Warts | RESEARCH | Lesions | Neoplasia | Population control | Vaccination | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | PARTICLE VACCINE | EXTERNAL GENITAL WARTS | CLINICAL-TRIALS | PREVENTION | TERMINOLOGY | INFECTION | HEALTH | CANCER | LESIONS | Double-Blind Method | Humans | Uterine Cervical Neoplasms - prevention & control | Treatment Outcome | Carcinoma in Situ - prevention & control | Condylomata Acuminata - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Young Adult | Papillomavirus Infections - prevention & control | Vaginal Neoplasms - prevention & control | Cancer Vaccines | Vulvar Neoplasms - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Adult | Female | Urogenital Neoplasms - prevention & control | Papillomavirus Vaccines | Papillomavirus Infections: prevention & control | Basic Medicine | Condylomata Acuminata: prevention & control | Medical and Health Sciences | Medicin och hälsovetenskap | Urogenital Neoplasms: prevention & control | Mikrobiologi inom det medicinska området | Uterine Cervical Neoplasms: prevention & control | Vaginal Neoplasms: prevention & control | Carcinoma in Situ: prevention & control | Microbiology in the medical area | Cervical Intraepithelial Neoplasia: prevention & control | Medicinska och farmaceutiska grundvetenskaper | Vulvar Neoplasms: prevention & control
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2007, Volume 356, Issue 19, pp. 1928 - 1943
Journal Article
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 5, pp. F123 - F138
Highlights ► The analyses of human papilloma virus/virus-like particle vaccine phase III efficacy trials in young women are largely completed. ► High efficacy... 
Allergy and Immunology | Prophylactic vaccine | Genital warts | Virus-like particle | Gardasil | Clinical trials | VaIN | CIN | VIN | Cervical cancer | HPV | Cervarix | Vain | Cin | Vin | Hpv | MEDICINE, RESEARCH & EXPERIMENTAL | Cervarix (R) | (HPV)-16/18 AS04-ADJUVANTED VACCINE | OF-STUDY ANALYSIS | Gardasil (R) | CERVICAL-CANCER | IMMUNOLOGY | GRADE 3 | IMMUNOGENICITY | PARTICLE VACCINE | DOUBLE-BLIND | POOLED ANALYSIS | YOUNG-WOMEN | HPV TYPES | Vaccines, Virus-Like Particle - adverse effects | Papillomavirus Infections - complications | Humans | Condylomata Acuminata - virology | Uterine Cervical Neoplasms - prevention & control | Vulvar Neoplasms - virology | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Male | Vaginal Neoplasms - virology | Condylomata Acuminata - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Clinical Trials, Phase III as Topic | Vaccines, Virus-Like Particle - administration & dosage | Papillomavirus Infections - prevention & control | Vaginal Neoplasms - prevention & control | Vulvar Neoplasms - prevention & control | Papillomavirus Vaccines - adverse effects | Uterine Cervical Neoplasms - virology | Female | Papillomavirus Vaccines - immunology | Vaccines, Virus-Like Particle - immunology | Papillomavirus Vaccines - administration & dosage | Dysplasia | Care and treatment | Oncology, Experimental | Vaccines | Research | Papillomaviruses | Warts | Health aspects | Papillomavirus infections | Public health | Cancer | Human papillomavirus
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 02/2014, Volume 311, Issue 6, pp. 597 - 603
IMPORTANCE Determining vaccine dose-level protection is essential to minimize program costs and increase mass vaccination program feasibility. Currently, a... 
UNITED-STATES | ANOGENITAL WARTS | CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | IMMUNOGENICITY | EFFICACY | ADOLESCENTS | HPV VACCINE | GENITAL WARTS | NATURAL-HISTORY | YOUNG-WOMEN | Humans | Uterine Cervical Neoplasms - prevention & control | Condylomata Acuminata - epidemiology | Human papillomavirus 6 | Sweden - epidemiology | Condylomata Acuminata - prevention & control | Incidence | Vaccination - statistics & numerical data | Young Adult | Papillomavirus Infections - prevention & control | Registries - statistics & numerical data | Cost-Benefit Analysis | Human papillomavirus 11 | Adolescent | Female | Child | Papillomavirus Vaccines - administration & dosage | Cohort Studies | Human papillomavirus | Vaccines | Drug dosages | Risk assessment | Clinical outcomes | Viral infections | Papillomavirus Infections: prevention & control | Papillomavirus Vaccines: administration & dosage | Hälsovetenskap | Condylomata Acuminata: prevention & control | Medical and Health Sciences | Medicin och hälsovetenskap | Dermatologi och venereologi | Dermatology and Venereal Diseases | Klinisk medicin | Uterine Cervical Neoplasms: prevention & control | Environmental Health and Occupational Health | Clinical Medicine | Registries: statistics & numerical data | Sweden: epidemiology | Arbetsmedicin och miljömedicin | Vaccination: statistics & numerical data | Condylomata Acuminata: epidemiology | Health Sciences
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2013, Volume 105, Issue 7, pp. 469 - 474
Journal Article